We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Investigational Urine Test Aids Appendicitis Diagnosis

By LabMedica International staff writers
Posted on 20 Aug 2009
An experimental pediatric urine test could one day spot appendicitis faster and more accurately than current tests, claims a new study.

Researchers at Children's Hospital Boston (CHB, MA, USA) first examined urine samples from six patients with appendicitis and six without appendicitis. More...
The researchers then identified 32 possible associated biomarkers; to these, they added 25 other markers found in gene studies. The researchers then looked for these 57 potential markers in 67 children with possible appendicitis; among these children, 25 actually did have appendicitis. Tests of performance of the markers were evaluated against the pathologic diagnosis and histologic grade of appendicitis. The researchers eventually identified seven biomarkers linked with appendicitis that exhibited favorable diagnostic performance, including calgranulin A (S100-A8), alpha-1-acid glycoprotein 1 (orosomucoid), and leucine-rich alpha-2-glycoprotein (LRG). LRG especially was enriched in diseased appendices, and its abundance correlated with severity of appendicitis. The study was published ahead of print in the June 23, 2009, online edition of the Annals of Emergency Medicine.

"We have found a protein in the urine that is diagnostic for appendicitis,” said study co-author Hanno Steen, Ph.D., director of the proteomics center at CHB. "This would mean that diagnosis of appendicitis is faster, more reliable and much more cost-efficient.”

Ultrasound and computed tomography (CT) scans are currently used to diagnose appendicitis, yet 3-30% of children have unnecessary appendectomies, while 30-45% of those diagnosed with appendicitis already have a ruptured appendix. In addition, patients can wait hours in the emergency room before they are able to have these tests; the new test could diagnose appendicitis in just 30 minutes and result in fewer unnecessary surgeries. However, the test still needs to be validated in adults.

Related Links:
Children's Hospital Boston



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.